This week on MedHeads we’re talking about where Alphabet (and Google) really fit and make an impact in healthcare and what their real goals are.
As our own Stephanie Baum pointed out in an article this week:
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“For anyone hoping for juicy details about Alphabet’s healthcare and life science interests, its fourth quarter earnings call offered slim pickings. But if you listened to the bigger picture, the push to reorganize Google’s cloud-based business offered plenty to think about. The company made frequent references to machine learning and apps in its Google for Work services, and the growth of mobile search.”
So we can see a lot of potential, sure. But how does that actually materialize and look moving forward this year?
Chris Seper will moderate – Stephanie Baum and Meghana Keshevan will join the discussion with our guest Mark Bergen from Re/Code about the subject, who is clearly interested in what the company is up to and who is involved.
Tune into MedHeads at 1 p.m. Eastern this Friday. Join us via the YouTube embed below or on our Google Hangout Hangouts On Air page.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
